StreetAlpha
13F holdings · Q3 2026

Farallon Capital Management, L.l.c.

San Francisco, CA · files as Farallon Capital Management, L.l.c.
Know the moment Farallon Capital Management, L.l.c. filesYou follow Farallon Capital Management, L.l.c. An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 909661

Farallon Capital Management, L.l.c. reported 110 stocks worth $18.7B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (14.8%), Warner Bros Discovery in (8.2%) and NTRA (5.8%). Compared with Q2 2026, the fund opened new positions in ROKU, CRH and ASBH, added to NTRA, BBIO and PTGX, trimmed RVMD, AMZN and GRAL and sold out of NVO, MRK and WRBY.

Latest filing: what Farallon Capital Management, L.l.c. did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
46 new23 added19 trimmed21 sold outBought about $3.4B · sold about $3.7B
New 46
See all 46 →
Added 23
  • Warner Bros Discov+$658M+76%
  • ROIV+$272M+52%
  • BBIO+$231M+33%
  • NTRA+$158M+17%
  • BIIB+$138M+859%
See all 23 →
Trimmed 19
See all 19 →
Sold out 21
  • Electronic Arts In$1.6B
  • Crinetics Pharmace$336M
  • Apogee Therapeutic$141M
  • NVO$126M
  • MRK$25.6M
See all 21 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$18.7B+1.9% vs last quarter · $22.7B including options
Stocks held11046 new · 21 sold out
Top 5 weight38.6%fairly concentrated
Turnover38%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
RVMD
Revolution Medicines Inc
$2.8B14.8%13.4M−132K (−1%)8 of 8
2
WARNER BROS DISCOVERY IN
$1.5B8.2%49.4M+21.3M (+76%)4 of 8
3
NTRA
Natera Inc
$1.1B5.8%2.6M+381K (+17%)8 of 8
4
BBIO
Bridgebio Pharma Inc
$937M5.0%14.2M+3.5M (+33%)8 of 8
5
PTGX
Protagonist Therapeutics Inc
$907M4.9%6.4M+89K (+1%)8 of 8
6
EXEL
Exelixis Inc
$858M4.6%14.7M+1.2M (+9%)8 of 8
7
ROIV
Roivant Sciences Ltd
$795M4.3%21.7M+7.4M (+52%)8 of 8
8
ROKU
Roku Inc Class A
$633M3.4%4.2MNew position1 of 8
9
AMZN
Amazon Com Inc
$590M3.2%2.4M−265K (−10%)6 of 8
10
GRAL
Grail Inc
$570M3.1%4.1M−92K (−2%)6 of 8
🔒 100 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ELECTRONIC ARTS INC
$1.6B7.9M
CRINETICS PHARMACEUTICALS IN
$336M9M
APOGEE THERAPEUTICS INC
$141M1.1M
NVO
Novo-Nordisk A S F
$126M2.6M
MRK
Merck & Co Inc
$25.6M199K

🔒 Free account: see all 21.

Options

valued at the underlying shares
StockTypeValueSharesChange
SPY
Spdr S&P 500 ETF TR
Put$4B5.2M−780,000
IBIT
Ishares Bitcoin Trust ETF
Put$43.4M917K+916,800

Reported value

last 8 quarters
$18.9BQ4 '24
$18.5BQ1 '25
$21.9BQ2 '25
$17.7BQ3 '25
$20.3BQ4 '25
$18.2BQ1 '26
$18.3BQ2 '26
$18.7BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Farallon Capital Management, L.l.c. 13F FAQ

What does Farallon Capital Management, L.l.c. own?

Farallon Capital Management, L.l.c. reported 110 stocks worth $18.7B in its 13F filing for Q3 2026, filed Nov 16, 2026. The table above lists every position in the filing (the top 10 without an account).

What did Farallon Capital Management, L.l.c. buy and sell in Q3 2026?

Compared with Q2 2026: 46 new positions, 23 added to, 19 trimmed and 21 sold out. New positions include ROKU, CRH and ASBH. It sold all of NVO, MRK and WRBY.

When will Farallon Capital Management, L.l.c. file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Farallon Capital Management, L.l.c.'s portfolio worth?

The Q3 2026 filing reports $18.7B in US stocks ($22.7B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.